Bradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.